288 related articles for article (PubMed ID: 23463091)
1. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage.
Migita K; Takayama T; Saeki K; Matsumoto S; Wakatsuki K; Enomoto K; Tanaka T; Ito M; Kurumatani N; Nakajima Y
Ann Surg Oncol; 2013 Aug; 20(8):2647-54. PubMed ID: 23463091
[TBL] [Abstract][Full Text] [Related]
2. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
3. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
4. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer.
Eo WK; Chang HJ; Suh J; Ahn J; Shin J; Hur JY; Kim GY; Lee S; Park S; Lee S
Nutr Cancer; 2015; 67(8):1260-7. PubMed ID: 26583916
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M
Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
9. Ten-year survival of curability B gastric cancer patients treated by tegafur-uracil as postoperative adjuvant chemotherapy in a common public hospital: univariate and multivariate analyses.
Okuyama T; Higashi T; Edagawa A; Nagata S; Hashimoto K; Saeki H; Oki E; Uchiyama H; Kawanaka H; Morita M; Tateishi M; Korenaga D; Yaita H; Takenaka K
Fukuoka Igaku Zasshi; 2012 Jul; 103(7):138-44. PubMed ID: 22978066
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
11. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.
Sasako M; Sakuramoto S; Katai H; Kinoshita T; Furukawa H; Yamaguchi T; Nashimoto A; Fujii M; Nakajima T; Ohashi Y
J Clin Oncol; 2011 Nov; 29(33):4387-93. PubMed ID: 22010012
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
14. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy.
Kunisaki C; Takahashi M; Ono HA; Oshima T; Takagawa R; Kimura J; Kosaka T; Makino H; Akiyama H; Endo I
Oncology; 2012; 83(4):183-91. PubMed ID: 22890015
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Zhang RP; Liang H
World J Gastroenterol; 2014 Aug; 20(30):10537-44. PubMed ID: 25132773
[TBL] [Abstract][Full Text] [Related]
17. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer.
Kanda M; Mizuno A; Tanaka C; Kobayashi D; Fujiwara M; Iwata N; Hayashi M; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Takami H; Niwa Y; Murotani K; Kodera Y
Medicine (Baltimore); 2016 Jun; 95(24):e3781. PubMed ID: 27310954
[TBL] [Abstract][Full Text] [Related]
18. Low Preoperative Prognostic Nutritional Index Predicts Poor Survival Post-gastrectomy in Elderly Patients with Gastric Cancer.
Sakurai K; Tamura T; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Yashiro M; Maeda K; Ohira M; Hirakawa K
Ann Surg Oncol; 2016 Oct; 23(11):3669-3676. PubMed ID: 27207098
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.
Nakajima T; Kinoshita T; Nashimoto A; Sairenji M; Yamaguchi T; Sakamoto J; Fujiya T; Inada T; Sasako M; Ohashi Y;
Br J Surg; 2007 Dec; 94(12):1468-76. PubMed ID: 17948223
[TBL] [Abstract][Full Text] [Related]
20. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
